基于可信计算的Ad Hoc网络安全模型研究(英文)

来源 :中国通信 | 被引量 : 0次 | 上传用户:yueyingz4l
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
With the rapid development of wireless networks,the Ad Hoc networks are widely used in many fields,but the current network security solutions for the Ad Hoc network are not competitive enough.So the critical technology of Ad Hoc network applications shall be how to implement the security scheme.Here the discussions are focused on the specific solution against the security threats which the Ad Hoc networks will face,the methodology of a management model which uses trusted computing technology to solve Ad Hoc network security problems,and the analysis and verification for the security of this model. With the rapid development of wireless networks, the Ad Hoc networks are widely used in many fields, but the current network security solutions for the Ad Hoc network are not competitive enough. So the critical technology of Ad Hoc network applications shall be how to implement the security scheme. Here the discussions are focused on the specific solutions against the security threats which the Ad Hoc networks will face, the methodology of a management model which uses trusted computing technology to solve Ad Hoc network security problems, and the analysis and verification for the security of this model.
其他文献
目的评估MARS人工肝支持系统治疗对肝衰竭病人内分泌系统的影响,以评价MARS治疗对患者血液中对人体有用物质的影响,从而进一步了解MARS治疗对病人的影响. 方法采用放射免
会议
人工肝支持系统简称人工肝,目前已成为治疗重型肝炎和肝功能衰竭的重要治疗手段,随着研究的深入和技术的成熟,各种类型的人工肝在临床应用日趋广泛.但由于国内普遍开展人工肝
会议
人工肝血浆置换已广泛应用于肝衰竭的治疗中.他的良好疗效及安全可靠性并不是没有风险的.重型肝衰竭患者病情变化的复杂、危重、给治疗造成了极大的困难和风险.近年来我们应
目的探讨人工肝支持系统治疗暂时血液通路的设计与建立. 方法通过对本院36次人工肝治疗,体会如何建立完善的暂时血液通路. 结果人工肝支持系统治疗应用暂时血液通路最
历时六载,易稿数十次的《中华人民共和国证券法》(以下简称《证券法》)在1998年12月29日九届全国人大常委会第六次会议上以135票的高票数获得通过,标志着我国证券市场步入了依法治市的崭新阶
目的探讨血浆置换(PlasmaExchangePE)联合血液透析(HemodialysisHD)治疗重型肝炎合并肝肾综合征的临床疗效. 方法32名重型肝炎合并肝肾综合征患者分为治疗组15例,对照组17
Recent developments show a progressing convergence of networks, services, and applications, which results in the necessity for new approaches to provide a ubiqu
人工肝支持系统是目前治疗慢性重型肝炎较为有效的手段之一.我院运用日本的PlasautoiQ人工肝治疗机对70例的重型肝炎患者进行了单纯血浆置换治疗,取得了一定的疗效.本文着重
会议
目的评价分子吸附再循环系统(MARS)治疗重型肝炎的临床疗效,应用终末期肝病评分模型(MELD),观察它对重型肝炎预后的预测作用. 方法27例重型肝炎患者在内科综合治疗基础上
会议
为了改善重型肝炎患者临床症状,清除体内有毒代谢产物,创造肝细胞再生条件.我们用血液灌流联合血液透析的方法对9例重型肝炎并肝肾综合症和肝性脑病患者进行治疗. 结果:胆
会议